Wei Jiang

11PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 10, 2026
ZNF844 Suppresses Invasion and Metastasis in Nasopharyngeal Carcinoma by Inhibiting the PI3K-AKT Signaling Pathway.

Jinping Xu, Cancan Chen, Bin Zhang

|Sep 29, 2025
Efficacy and Safety of Vascular-Targeting Agents Plus Chemotherapy Versus Chemotherapy Alone in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients: A Multicenter Clinical Cohort Study.

Guanhong Luo, Jinping Xu, Guanjie Qin

|Mar 10, 2025
Influence of COVID-19 Vaccination on Treatment-Related Adverse Events and Oncologic Outcomes of Nonmetastatic Nasopharyngeal Carcinoma.

Minglong Liu, Bin Zhang, Yufei Pan

|Mar 20, 2024
Reduced-Volume Irradiation of Uninvolved Neck in Patients With Nasopharyngeal Cancer: Updated Results From an Open-Label, Noninferiority, Multicenter, Randomized Phase III Trial.

Cheng-Long Huang, Ning Zhang, Wei Jiang

|Feb 07, 2024
Intensity-modulated radiotherapy alone compared with intensity-modulated radiotherapy plus concurrent chemotherapy in intermediate-risk nasopharyngeal carcinoma : A prospective multicenter phase II trial.

Shufang Liao, Bin Zhang, Yixin Su

|Aug 12, 2021
Methylation-associated silencing of miR-9-1 promotes nasopharyngeal carcinoma progression and glycolysis via HK2.

Qian-Lan Xu, Zan Luo, Bin Zhang

Pageof 2

Frequent Collaborators

2 joint publications

Ying Sun

1 joint publications

Jun Ma

1 joint publications

Cheng-Long Huang

1 joint publications

Xiao-Qing Pei